Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSherborne Inv C Regulatory News (SIGC)

Share Price Information for Sherborne Inv C (SIGC)

Share Price is delayed by 15 minutes
Get Live Data
32.20    0.00 (0.00%)
Bid:
31.40
Ask:
33.00
Spread: 1.60 (5.096%)
Market Cap: £208.46m
SIGC Live PriceLast checked at - London Stock Exchange

Intraday Sherborne Inv C Share Chart

Directorate Change

27 Aug 2025 07:00

RNS Number : 7571W
Sherborne Investors (Guernsey)C Ltd
27 August 2025
 

Sherborne Investors (Guernsey) C Limited

LEI 213800L8QL59OCFOCB40

27 August 2025

 

Sherborne Investors (Guernsey) C Limited

Directorate Change

 

Sherborne Investors (Guernsey) C Limited (the "Company") is pleased to announce the appointment of James Christie to the Board as a non-executive director with effect from 1 September 2025.

James, a Guernsey resident, is a highly experienced financial services professional with a career spanning over 25 years in the fund administration services and fund management industries. His experience covers private and public companies invested in private equity, real estate, infrastructure, debt and energy. He has held a range of board appointments for fund management and licensed fund investment companies which has resulted in a strong focus on corporate governance and risk management.

He is currently executive director at Oak Fund Services (Guernsey) Limited with responsibility for client relationships and the delivery of fund administration services.

James was awarded an MBA from Henley Management College in 2001 and is a member of the Chartered Institute of Securities and Investment.

Talmai Morgan, Chair of the Company, commented: "I am delighted to welcome James to the Board. His corporate governance expertise, experience and knowledge of the funds industry will be of significant value to the Company and I look forward to working with him."

The Company confirms that there is no further information to be disclosed pursuant to paragraph LR 9.6.13R of the Listing Rules of the Financial Conduct Authority with regard to this appointment.

 -Ends-

Enquiries:

DGA Group +44 (0)20 7664 5095

Jonathon Brill

James Styles

 

Deutsche Numis (Broker) +44 (0)20 7260 1000

Nathan Brown

George Shiel

 

Sherborne Investors (Guernsey) C Limited   +44 (0)20 3530 3600

Talmai Morgan (Chair)

Matt Lihou (Apex, Company Secretary)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZGZRNVZGKZM
Date   Source Headline
1st Nov 20247:00 amRNSNet Asset Value(s)
11th Oct 20246:07 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSNet Asset Value(s)
4th Sep 20247:00 amRNSDividend Declaration
4th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20247:00 amRNSNet Asset Value(s)
1st Aug 20247:00 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSNet Asset Value(s)
3rd Jun 20247:00 amRNSNet Asset Value(s)
21st May 20242:51 pmRNSResult of AGM
9th May 20247:00 amRNSNotice of AGM
1st May 20247:00 amRNSNet Asset Value(s)
30th Apr 20246:00 pmRNSAnnual Financial Report
30th Apr 20245:57 pmRNSDividend Declaration
30th Apr 20245:54 pmRNSFinal Results
2nd Apr 20247:00 amRNSNet Asset Value(s)
1st Mar 20247:00 amRNSNet Asset Value(s)
1st Feb 20247:00 amRNSNet Asset Value(s)
2nd Jan 20247:00 amRNSNet Asset Value(s)
1st Dec 20237:00 amRNSNet Asset Value(s)
1st Nov 20237:00 amRNSNet Asset Value(s)
25th Oct 20237:00 amRNSDirectorate Change
2nd Oct 20237:00 amRNSNet Asset Value(s)
5th Sep 20237:00 amRNSDividend Declaration
5th Sep 20237:00 amRNSHalf-year Report
1st Sep 20237:00 amRNSNet Asset Value(s)
1st Aug 20237:00 amRNSNet Asset Value(s)
3rd Jul 20237:00 amRNSNet Asset Value(s)
1st Jun 20237:00 amRNSNet Asset Value(s)
23rd May 20233:14 pmRNSResult of AGM
18th May 20237:00 amRNSInvestment Update
3rd May 20237:00 amRNSNotice of AGM
2nd May 20237:00 amRNSNet Asset Value(s)
20th Apr 20237:00 amRNSDividend Declaration
20th Apr 20237:00 amRNSAnnual Financial Report
20th Apr 20237:00 amRNSAnnual Financial Report
3rd Apr 20237:00 amRNSNet Asset Value(s)
21st Mar 20237:00 amRNSHolding(s) in Company
1st Mar 20237:00 amRNSNet Asset Value(s)
1st Feb 20237:00 amRNSNet Asset Value(s)
16th Jan 20237:00 amRNSDirectorate Change
3rd Jan 20237:00 amRNSNet Asset Value(s)
1st Dec 20227:00 amRNSNet Asset Value(s)
1st Nov 20227:00 amRNSNet Asset Value(s)
31st Oct 20226:00 pmRNSHolding(s) in Company
28th Oct 20226:00 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSNet Asset Value(s)
1st Sep 20227:00 amRNSNet Asset Value(s)
18th Aug 20227:00 amRNSDividend Declaration
18th Aug 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.